Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
ASTRAZEN Stock Analysis
Views
Red Flags
Positive
Strong price momentum
High and improving ROE
Moderate operating margin but improving trend
Strong revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
ASTRAZEN Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
ASTRAZEN Bulk, Block & Insider Trades
ASTRAZEN Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Bonus(1 new shares for 1 existing shares) Ex-date: 14th Nov 1995 Announced on: 7th Nov 1995
Stock split(2 : 10)Nominal value change from Rs. 10 to Rs. 2 Ex-date: 15th Jun 2006 Announced on: 6th Jun 2006
Company Profile
AstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution... Read More
Key personnel
Ms. Shilpa Divekar NirulaD
Non-Executive Independent Chairman of the Board
Mrs. Bhavana AgrawalD
Chief Financial Officer, Whole-time Director
Mr. Praveen Rao AkkinepallyD
Managing Director, Executive Director
Ms. Hooi-Bien ChuahD
Non-Executive Director
Mr. Jesus Javier Diaz Roper EstesoD
Non-Executive Director
Ms. Sylvia Lorena Varela RamonD
Non-Executive Director
Ms. Revathy AshokD
Non-Executive Independent Director
Ms. Monica WidhaniD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Astrazeneca Pharma India Ltd.?
The current share price of Astrazeneca Pharma India Ltd. is ₹ 8,333.67 as of 09 Jan 2026.
What is the PE ratio of Astrazeneca Pharma India Ltd.?
The Price-to-Earnings (PE) ratio of Astrazeneca Pharma India Ltd. is 104.61 as of the latest financial data.
What is the ROE and ROCE of Astrazeneca Pharma India Ltd.?
Astrazeneca Pharma India Ltd. has a Return on Equity (ROE) of 26.94% and a Return on Capital Employed (ROCE) of 31.93% as per the latest financial reports.
What is the market cap of Astrazeneca Pharma India Ltd.?
The market capitalization of Astrazeneca Pharma India Ltd. stands at ₹ 20,834.20 Cr.
What is the dividend yield of Astrazeneca Pharma India Ltd.?
The dividend yield of Astrazeneca Pharma India Ltd. is 0.38% based on the current market price.
What is the RSI of Astrazeneca Pharma India Ltd.?
The Relative Strength Index (RSI) of Astrazeneca Pharma India Ltd. is 29.05.
What is the FII and DII holding in Astrazeneca Pharma India Ltd.?
Foreign Institutional Investors (FII) hold 2.74% and Domestic Institutional Investors (DII) hold 5.19% of Astrazeneca Pharma India Ltd. shares.
What sector does Astrazeneca Pharma India Ltd. belong to?
Astrazeneca Pharma India Ltd. operates in the Healthcare sector.
What is the beta of Astrazeneca Pharma India Ltd. stock?
The beta of Astrazeneca Pharma India Ltd. stock is 0.59, indicating its volatility relative to the broader market.
